Advertisement

A Double–Blind Controlled Clinical Trial of Haloperidol Decanoate and Fluphenazine Decanoate in the Maintenance Treatment of Schizophrenia

  • G. Chouinard
  • L. Annable
  • W. Campbell
  • D. Boisvert
  • J. Bradwejn

Abstract

In recent years the use of long-acting injectable neuroleptics in the maintenance treatment of schizophrenia has become increasingly common. Initial open studies carried out in schizophrenic inpatients have confirmed that the new depot neuroleptic, haloperidol decanoate, has antipsychotic properties (Deberdt et al., 1980; Suarez Richards et al., 1982; Viukari et al., 1982). A double-blind controlled study was carried out to compare the efficacy of haloperidol decanoate to fluphenazine decanoate in the maintenance treatment of schizophrenic outpatients.

Keywords

Maintenance Treatment Tardive Dyskinesia Brief Psychiatric Rate Scale Haloperidol Decanoate Fluphenazine Decanoate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cohen BM, Herschel M, Aoba A., Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites. Psychiatry Research 1: 199–208, 1979.PubMedCrossRefGoogle Scholar
  2. 2.
    Deberdt R, Elens P, Berghmans J, et al., Intramuscular haloperidol decanoate for neuroleptic maintenance therapy: Efficacy, dosage schedule and plasma levels. Acta psychiat scand 62: 356–363, 1980.PubMedCrossRefGoogle Scholar
  3. 3.
    Schooler NR, Kane JM., Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39: 486–487. 1982.PubMedGoogle Scholar
  4. 4.
    Suarez Richards M, Actis Data AC, Zelaschi NM, et al., Monthly haloperidol decanoate substitutes for daily neuroleptics in psychotic inpatients. Curr Ther Res 32: 586–589, 1982.Google Scholar
  5. 5.
    Viukari M, Salo H, Lamminsivu U, Gordin A., Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients. Acta psychiat scand 65: 301–308, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • G. Chouinard
    • 1
    • 2
    • 3
  • L. Annable
    • 1
    • 2
    • 3
  • W. Campbell
    • 1
    • 2
    • 3
  • D. Boisvert
    • 1
    • 2
    • 3
  • J. Bradwejn
    • 1
    • 2
    • 3
  1. 1.Clinical Psychopharmacology Unit, Allan Memorial InstituteRoyal Victoria HospitalMontrealCanada
  2. 2.Department of PsychiatryMcGill UniversityMontrealCanada
  3. 3.Research DepartmentHopital Louis-H. LafontaineMontrealCanada

Personalised recommendations